Find CMO/CDMOs that produce:
Finished formulation / FDF
Follow us
Plants in:
Established in: 2014
Production scale:
small
medium
large
Employees: 1000+
23 years of production experience
6 workshops and 9 production lines which has 100t/month production capacity
4 USDMFS & 5 CEPS & 200+ Patents
All certificates
Replies quickly
CDMO-CMO
Plants in:
Established in: 1886
Production scale:
medium
small
Employees: 275+
Raw materials, CMO and OTC products
Two GMP certified locations
Customisable (small-sized) packages
All certificates
Replies quickly
CDMO-CMO
Plants in:
Established in: 2023
Production scale:
small
medium
large
Employees: 1000+
Expertise in Conventional, Complex, and Niche Chemistries
End-to-end Support from early development to Commercial Phases
Comprehensive Analytical Support Facilities
All certificates
Replies quickly
CDMO-CMO
Plants in:
Established in: 1975
Production scale:
small
medium
large
Employees: 234
45+ years of experience in oral solid and nonsterile oral liquid
Specialization in pediatric, geriatric, and controlled-substance
Reliable and flexible full-service production partner
All certificates
Replies quickly
CDMO-CMO
Plants in:
Established in: 1934
Production scale:
large
small
medium
Employees: 1500
Full-Service CDMO with End-to-End Solutions
Reliable Global Distribution Operating in over 70 countries
Specialized in hormones, crystal-suspensions and complex injectables
All certificates
Replies quickly
CDMO-CMO
Plants in:
Established in: 2019
Production scale:
large
Employees: 10+
Focused on pharmaceutical industry
Reasonable price for the customers
Full service from R&D stage to commercial stage
All certificates
Replies quickly
Located in:
CDMO-CMO
All certificates
Replies slower than most
CDMO-CMO
Plants in:
Established in: 1987
Production scale:
medium
small
large
Employees: 50+
ISO 9001:2015 & SGS audited supplier
One-stop CDMO Solutions for APl and Key intermediates
Specialized in APIs & Pharmaceutical Intermediates for 37 years
All certificates
Replies quickly
CDMO-CMO
Plants in:
Established in: 2016
Production scale:
medium
small
Low Volume high value API Fill and Finish Service
In-line monitoring, SKAN Isolators, Highly Experienced Staff
Capacity Available, Ready for your API
All certificates
Replies quickly
CDMO-CMO
Plants in:
Established in: 2006
Production scale:
small
medium
Employees: 20
Quality Assurance: Products are manufactured from the finest raw materials and undergo rigorous testing.
Tailored Customisation & Compliance: Providing end-to-end solutions to meet your business
Dependable Expertise and Supply: Backed by years of industry experience and a robust supply chain.
All certificates
Replies quickly
CDMO-CMO
Plants in:
Established in: 1989
Production scale:
large
Employees: 5000+
6 production facilities approved by USFDA, AGES-Austria, PMDA, WHO
R&D Centers with capabilities of ANDAs, DMFs and NDDS
462+ patents filed for drug substances and polymorphs
All certificates
Replies quickly
CDMO-CMO
Plants in:
Established in: 1955
Production scale:
small
medium
large
Employees: 500+
BFS expertise with FDA Approval for Sterile Manufacturing
USA and European Quality
Innovative solutions for ophthalmology and otorhinolaryngology
All certificates
Replies quickly
CDMO-CMO
Plants in:
Established in: 1964
Production scale:
small
medium
large
Employees: 135+
Market leader in Switzerland
Small and medium batch sizes
Pharmaceutical raw materials with a herbal or synthetic basis
All certificates
Replies quickly
CDMO-CMO
Plants in:
Established in: 2005
Production scale:
medium
small
Employees: 200+
Portfolio of over 2,000 APIs
Precise quality control
End-to-end global regulatory support
All certificates
Replies quickly
Plants in:
Established in: 1982
Production scale:
small
Employees: 30+
Modern GMP facility
Team of academics and technical experts
Small to large batch sizes possible
All certificates
Replies quickly
CDMO-CMO
Specialized in complex product development and manufacturing.
High-quality standards with a focus on customer-specific needs.
Agile and innovative approach to CDMO services.
All certificates
Replies quickly
CDMO-CMO
Plants in:
Established in: 1972
Production scale:
medium
Employees: 1,000+
EU-GMP for APIs and CEP for certain APIs
Exporting to over 50 countries worldwide
Long-standing technological advantage in adamantane, quinuclidine and nitrofurane chemistry
All certificates
Replies quickly
CDMO-CMO
Specialized in sterile and non-sterile pharmaceutical manufacturing.
Focus on flexibility and customization for client-specific needs.
State-of-the-art technology ensuring quality and efficiency.
All certificates
Replies slower than most
CDMO-CMO
With 15 production sites in Europe and the USA
7 Development Centers of Excellence covering all dosage forms
13 locations with Technology Services on site for seamless Tech Transfer and product Life-Cycle Management
All certificates
Replies slower than most
CDMO-CMO
Specialized in sterile ophthalmic and injectable formulations.
Focus on flexibility and customization for client-specific needs.
Advanced manufacturing capabilities in a controlled environment.
All certificates
Replies slower than most
CDMO-CMO
Plants in:
Established in: 1942
Production scale:
large
Over 100 unique marketed pharmaceutical products and 17 approved product applications since 2019
Manufacturing capacities : 3.5B Oral Solid doses and 2.0M liters of liquids per year
We specialize in contract manufacturing of Oral Solid Dose (OSD) and Liquids, including high potency substances and small molecules.
All certificates
Replies slower than most
CDMO-CMO
Successfully inspected by TGA, PMDA, MHRA, ANVISA, Health Canada, MPA, IMB, & FDA
All facilities are in good standing with all regulatory authorities, including DEA, EPA, OSHA
Quality Management System and supporting analytical processes are almost 100% electronic
All certificates
Replies quickly
CDMO-CMO
Comprehensive drug development services from molecule to market.
Expertise in nanomedicine and drug repurposing.
Tailored project management ensuring efficiency and transparency.
All certificates
Replies slower than most
CDMO-CMO
Expertise in ophthalmic drug delivery solutions.
Committed to high-quality standards and patient safety.
Innovative R&D for advanced ophthalmic formulations.
All certificates
Replies slower than most
CDMO-CMO
Dedicated to high-quality ophthalmic and ENT product manufacturing.
Emphasis on natural and gentle formulations for sensitive applications.
Italian excellence in innovative product development and production.
All certificates
Replies slower than most
CDMO-CMO
Leading in aerosol and transdermal drug delivery systems.
Expertise in both small molecule and biologic drug formulation.
Strong track record in bringing complex therapies to market.
All certificates
Replies slower than most
CDMO-CMO
Plants in:
Established in: 1962
Production scale:
large
500 millions of lozenges per year at the Aignan site
143 million packs per year at the Gien site
252 formulations per year at the Cahors site
All certificates
Replies slower than most
CDMO-CMO
Specialized in liquid and semi-solid pharmaceuticals manufacturing.
Nordic excellence in quality and reliability.
Flexible production capabilities catering to a wide range of batch sizes.
All certificates
Replies slower than most
CDMO-CMO
Leaders in dermatological product development and testing.
Innovative solutions for skin permeation and absorption studies.
Strong focus on client-centric, scientifically driven services.
All certificates
Replies slower than most
CDMO-CMO
Pioneering in advanced delivery technologies and development solutions.
Extensive global network ensuring supply chain resilience.
Tailored services across biologics, gene therapies, and pharmaceuticals.
All certificates
Replies slower than most
CDMO-CMO
Innovator in blow-fill-seal technology for sterile liquid dosages.
Expertise in unit dose packaging for ophthalmics and respiratory solutions.
State-of-the-art facilities ensuring precision and scalability.
All certificates
Replies slower than most
CDMO-CMO
Leading global provider of plasma-derived medicines.
Strong focus on innovation in bioscience solutions.
Comprehensive services from plasma collection to finished product.
All certificates
Replies slower than most
CDMO-CMO
Plants in:
Established in: 2017
Production scale:
large
Specialized in API and intermediate manufacturing with a focus on quality.
Advanced R&D capabilities for complex chemistry challenges.
Competitive pricing with a commitment to timely delivery.
All certificates
Replies slower than most
CDMO-CMO
Advanced polymers technology for optimized drug delivery systems.
Global capabilities in complex formulations and specialty chemicals.
Emphasis on collaborative partnerships for innovative solutions.
All certificates
Replies slower than most
CDMO-CMO
Plants in:
Established in: 1954
Production scale:
large
Employees: 22,000
Global flexibility with 16 manufacturing sites
More than 50 products commercialized over 60 years
22,000 employees, with 2,900 dedicated to R&D
All certificates
Replies slower than most
Looking for CMO/CDMO Services?
Find a list of providers specializing in CMOs/CDMOs Services for Finished formulation / FDF. Navigate through our extensive selection to identify the supplier that aligns with your specific needs.
Pharmaoffer makes it easy and convenient to send inquiries at no cost. Directly connect with your chosen supplier and take the first step towards fulfilling your pharmaceutical needs easily and efficiently.
CMO/CDMO - Contract (Development) Manufacturing Organizations
CDMOs and CMOs are pivotal in the pharmaceutical and biotech industries, offering specialized services in drug development and manufacturing. They assist in scaling up production from laboratory to commercial quantities, while adhering to strict regulatory standards. These organizations play a crucial role in the efficient and cost-effective production of medical and pharmaceutical products, ensuring quality and compliance at every stage.
Finished formulation / FDF
Finished Formulation CMOs/CDMOs focus on the final stage of pharmaceutical product manufacturing, which involves blending and formulating active pharmaceutical ingredients (APIs) into finished dosage forms like tablets, capsules, liquid formulations, and injectables.
Pharmaoffer showcases a range of Contract Manufacturing Organizations (CMOs) and Contract Development and Manufacturing Organizations (CDMOs) that specialize in Finished Formulation. These organizations, key players in FDF (Finished Dosage Formulations) manufacturing, are essential in the pharmaceutical industry, focusing on the final stage of product manufacturing – blending and formulating APIs into finished dosage forms.
Key Services Provided by Finished Formulation CMOs/CDMOs:
Diverse Dosage Form Production: Expertise in creating a wide array of finished dosage forms, including tablets, capsules, oral liquids, powders, and more. This service is a critical aspect of FDF CDMO offerings.
High-Quality Formulation Development: Developing formulations that ensure efficacy, stability, and patient acceptability, adhering to precise pharmaceutical standards. This includes specialized formulation services and CDMO formulation development.
Advanced Manufacturing Processes: Utilizing state-of-the-art manufacturing processes and equipment to produce high-quality finished pharmaceutical products. This is a key component of CDMO products and contract formulation services.
Regulatory Compliance and Quality Assurance: Ensuring all products meet stringent regulatory standards, including compliance with FDA, EMA, and other regulatory bodies’ guidelines.
Customized Manufacturing Solutions: Offering tailored solutions to meet the unique needs of different pharmaceutical products, from small-scale batches to large-scale commercial production. This flexibility is essential in the realm of FDF manufacturing.
Connect with Expert Finished Formulation Providers
Through Pharmaoffer, you can explore and connect with CMOs/CDMOs that specialize in Finished Formulation services. Our platform provides access to organizations equipped with the expertise and technology necessary for the efficient and compliant production of finished pharmaceutical products.
